Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Monga

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Gene Expression|February 8, 2018
The Effect of Selective c-MET Inhibitor on Hepatocellular Carcinoma in the MET-Active, β-Catenin-Mutated Mouse ModelNa Zhan, Adeola Adebayo Michael, Kaiyuan Wu, et al.
Molecular and Cellular Biology|February 2, 2021
Scaffolding Protein IQGAP1 Is Dispensable, but Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 SignalingEvan R Delgado, Hanna L Erickson, Junyan Tao, et al.
Hepatology (Baltimore, Md.)|April 2, 2004
Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regenerationChristoph Köhler, Aaron W Bell, William C Bowen, et al.
The American Journal of Pathology|March 17, 2018
Bromodomain and Extraterminal (BET) Proteins Regulate Hepatocyte Proliferation in Hepatocyte-Driven Liver RegenerationJacquelyn O Russell, Sungjin Ko, Harvinder S Saggi, et al.
Cell Transplantation|April 11, 2001
Expansion of hepatic and hematopoietic stem cells utilizing mouse embryonic liver explantsS P Monga, Y Tang, F Candotti, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Therapeutic potential of SOX9 dysruption in Combined Hepatocellular Carcinoma-CholangiocarcinomaYoojeong Park, Shikai Hu, Minwook Kim, et al.
Cells|September 14, 2024
Context-Dependent Distinct Roles of SOX9 in Combined Hepatocellular Carcinoma-CholangiocarcinomaYoojeong Park, Shikai Hu, Minwook Kim, et al.
BMC Cancer|November 14, 2018
Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in miceYu Qiao, Meng Xu, Junyan Tao, et al.
The American Journal of Pathology|September 12, 2018
High Frequency of β-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor AgonistSandra Mattu, Christian Saliba, Pia Sulas, et al.
Oncogene|March 23, 2011
β-Catenin is required for Ron receptor-induced mammary tumorigenesisP K Wagh, J K Gray, G M Zinser, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Gene Expression|February 8, 2018
The Effect of Selective c-MET Inhibitor on Hepatocellular Carcinoma in the MET-Active, β-Catenin-Mutated Mouse ModelNa Zhan, Adeola Adebayo Michael, Kaiyuan Wu, et al.
Molecular and Cellular Biology|February 2, 2021
Scaffolding Protein IQGAP1 Is Dispensable, but Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 SignalingEvan R Delgado, Hanna L Erickson, Junyan Tao, et al.
Hepatology (Baltimore, Md.)|April 2, 2004
Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regenerationChristoph Köhler, Aaron W Bell, William C Bowen, et al.
The American Journal of Pathology|March 17, 2018
Bromodomain and Extraterminal (BET) Proteins Regulate Hepatocyte Proliferation in Hepatocyte-Driven Liver RegenerationJacquelyn O Russell, Sungjin Ko, Harvinder S Saggi, et al.
Cell Transplantation|April 11, 2001
Expansion of hepatic and hematopoietic stem cells utilizing mouse embryonic liver explantsS P Monga, Y Tang, F Candotti, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Therapeutic potential of SOX9 dysruption in Combined Hepatocellular Carcinoma-CholangiocarcinomaYoojeong Park, Shikai Hu, Minwook Kim, et al.
Cells|September 14, 2024
Context-Dependent Distinct Roles of SOX9 in Combined Hepatocellular Carcinoma-CholangiocarcinomaYoojeong Park, Shikai Hu, Minwook Kim, et al.
BMC Cancer|November 14, 2018
Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in miceYu Qiao, Meng Xu, Junyan Tao, et al.
The American Journal of Pathology|September 12, 2018
High Frequency of β-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor AgonistSandra Mattu, Christian Saliba, Pia Sulas, et al.
Oncogene|March 23, 2011
β-Catenin is required for Ron receptor-induced mammary tumorigenesisP K Wagh, J K Gray, G M Zinser, et al.
Pageof 16